Slow down and take a step back. This is a blinded trial. We are blinded. Resverlogix is blinded. Clinical Steering committee is blinded. Patients are blinded  Investigators are blinded. If that is true, then there is no way Resverlogix or Third Eye would or could have any idea of the actual relative risk reduction or other associated unblinded data. Unblinding the trial would be a serious mistake and would undermine the integrity of this CVOT trial. 

BearDownAZ